The analyses and visuals on this site are for informational purposes only and do not constitute investment advice.

© 2026 Datafin Financial Data Analysis Systems. All rights reserved. · v2.0

Privacy PolicyTerms of UseCookie Policy

IOVA FINANCIAL STATEMENTS

Iovance Biotherapeutics Inc — balance sheet, income statement and cash flow trends

IOVAIovance Biotherapeutics Inc

🇺🇸 USA · NASDAQ · Healthcare · Biotechnology

Value itDuel
PriceFinancialsPeers

Income Statement

Quarterly progression — trailing-twelve-month values
RevenueNet Income to Owners
-250 M0250 M202120222023202420252026

Profit Funnel

Q2 2026 · TTM
Revenue325 M $Gross Profit377.9 M $ · 116%Operating Income-301.3 M $ · -93%Pre-tax Income-293.8 M $ · -90%Net Income to Owners-289.5 M $ · -89%

Percentages are relative to revenue.

Key Figures

YoY change
Revenue325 M $+34.5%
Gross Profit377.9 M $+659.6%
Operating Income-301.3 M $—
EBITDA-262.8 M $—
Net Income to Owners-289.5 M $—

No peer data is available for this stock.

Balance Sheet

Quarterly period-end values
Total AssetsTotal LiabilitiesEquity
0500 M1 B202120222023202420252026

Capital Structure

Q2 2026
Total Assets915.5 M
  • Equity736 M $80%
  • Current Liabilities106.8 M $12%
  • Long-term Liabilities72.6 M $8%

Key Figures

YoY change
Total Assets915.5 M $+0.9%
Total Liabilities179.5 M $-14.1%
Total Equity736 M $+5.4%
Cash & ST Investments297.7 M $-1.2%
Total Debt46 M $-13.5%
Net Debt-64.8 M $—

No peer data is available for this stock.

Cash Flow Statement

Quarterly progression — trailing-twelve-month values
Operating Cash FlowCapital ExpendituresFree Cash Flow
-400 M-200 M0202120222023202420252026

Cash Flow Bridge

Q2 2026 · TTM
-300 M-200 M-100 M0-264.2 M $Operating-44.9 M $Investing287.9 M $Financing-21.2 M $Net Change

Key Figures

YoY change
Operating Cash Flow-264.2 M $—
Capital Expenditures32.2 M $+60.0%
Free Cash Flow-296.4 M $—
Dividends Paid——

No peer data is available for this stock.

Amounts are in the company’s reporting currency. Peer comparison tables use ratio-based metrics so currency differences do not distort the picture.

Go deeper on IOVA

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Sep 11, 26. This content is for informational purposes only and is not investment advice.